In a remarkable display of the convergence of megatrends, the year 2024 witnesses groundbreaking advancements in medicine, particularly in personalized cancer therapy. Moderna, renowned for its rapid development of the COVID-19 mRNA vaccine, is at the forefront of this revolution, leveraging AI, genetics, and cloud computing to offer hope to late-stage melanoma patients. This convergence